V
Vincent Cottin
Researcher at Claude Bernard University Lyon 1
Publications - 675
Citations - 29630
Vincent Cottin is an academic researcher from Claude Bernard University Lyon 1. The author has contributed to research in topics: Idiopathic pulmonary fibrosis & Medicine. The author has an hindex of 68, co-authored 574 publications receiving 21594 citations. Previous affiliations of Vincent Cottin include University of Lyon & Institut national de la recherche agronomique.
Papers
More filters
Journal ArticleDOI
Combination therapy: the future of management for idiopathic pulmonary fibrosis?
Wim A. Wuyts,Katerina M. Antoniou,Keren Borensztajn,Ulrich Costabel,Vincent Cottin,Bruno Crestani,Jan C. Grutters,Toby M. Maher,Venerino Poletti,Luca Richeldi,Carlo Vancheri,Athol U. Wells +11 more
TL;DR: The pleiotropic nature of disease pathogenesis in idiopathic pulmonary disease, the use of combination regimens in other selected chronic lung diseases, and the conceptual basis for combination therapies in interstitial lung disorders other than idiopATHic pulmonary fibrosis are reviewed.
Journal ArticleDOI
Interstitial lung disease associated with systemic sclerosis (SSc-ILD).
Vincent Cottin,Kevin K. Brown +1 more
TL;DR: Physicians managing patients with SSc should maintain a high level of suspicion and regularly monitor for ILD, particularly in the first few years after diagnosis, as well as investigate potential new therapies for SSc-ILD.
Journal ArticleDOI
Progression of idiopathic pulmonary fibrosis: lessons from asymmetrical disease
Colas Tcherakian,Vincent Cottin,Pierre-Yves Brillet,Olivia Freynet,Nicolas Naggara,Zohra Carton,Jean-François Cordier,Michel Brauner,Dominique Valeyre,Hilario Nunes +9 more
TL;DR: AIPF may be related to locoregional factors including gastro-oesophageal reflux which may be responsible for both disease expansion and the occurrence of acute exacerbations and survival was similar between patients with AIPF and controls.
Journal ArticleDOI
Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis
Caroline Kannengiesser,Raphael Borie,Christelle Ménard,Marion Reocreux,Patrick Nitschké,Steven Gazal,Steven Gazal,Hervé Mal,Camille Taillé,Jacques Cadranel,Hilario Nunes,Dominique Valeyre,Jean-François Cordier,Isabelle Callebaut,Catherine Boileau,Vincent Cottin,Bernard Grandchamp,Patrick Revy,Bruno Crestani +18 more
TL;DR: Evidence is provided that heterozygous RTEL1 mutations are responsible for FPF and, thereby, extend the clinical spectrum of RTEL 1 deficiency, which enlarges the number of telomere-associated genes implicated in FPF.
Journal ArticleDOI
Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management
Marlies S. Wijsenbeek,Michael Kreuter,Amy L. Olson,Aryeh Fischer,Elisabeth Bendstrup,Christopher D. Wells,Christopher P. Denton,Baher Mounir,Leila Zouad-Lejour,Manuel Quaresma,Vincent Cottin +10 more
TL;DR: It is estimated that 18–32% of patients diagnosed with non-IPF ILDs develop a progressive fibrosing phenotype and that these patients experience significant delays in the diagnosis of ILD and the detection of progressive fibrosis.